Tremfya is an innovative prescription medication used to treat plaque psoriasis, a chronic skin condition that affects millions of people around the world. But who is behind this revolutionary treatment? In this article, we’ll explore the story of Tremfya and the company responsible for creating and marketing it. We’ll learn about the research and development that went into creating this medication, as well as the company’s commitment to helping those living with psoriasis. So, let’s dive in and find out who makes Tremfya!
Tremfya is a medication for treating plaque psoriasis and is made by Janssen Biotech, Inc., part of Johnson & Johnson. It is a human monoclonal antibody that is taken as an injection. The medication helps reduce skin inflammation and clear up symptoms such as redness, itching, and scaling. It also helps skin lesions heal faster and can help improve quality of life.
Who Makes Tremfya?
Tremfya is a prescription medication used to treat moderate to severe plaque psoriasis. It is a prescription medicine developed by the biopharmaceutical company Janssen Pharmaceuticals, which is part of the Johnson & Johnson family of companies.
What is in Tremfya?
Tremfya is a human monoclonal antibody formulation that works by targeting and blocking the activity of a protein called interleukin-23 (IL-23). By blocking IL-23, Tremfya helps reduce inflammation caused by psoriasis.
What are the Benefits of Taking Tremfya?
Tremfya is a long-term treatment for moderate to severe plaque psoriasis. The medication helps reduce symptoms like redness, itching, and scaling of the skin. It can also help improve the overall quality of life for those living with psoriasis.
What are the Side Effects of Taking Tremfya?
Common side effects of taking Tremfya include:
- Headache
- Upper respiratory tract infection
- Joint pain
- Fatigue
- Diarrhea
- Nausea
- Inflammation of the sinuses (sinusitis)
It is important to speak with your doctor about any side effects you may be experiencing, as some may require medical attention.
Related FAQ
Who Makes Tremfya?
Answer: Tremfya is a prescription medication for the treatment of adults with moderate to severe plaque psoriasis. It is produced and marketed by Janssen Biotech, Inc., a subsidiary of Johnson & Johnson, a multinational American pharmaceutical company.
What is Tremfya Used For?
Answer: Tremfya is used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light). It helps reduce inflammation, itching, and other skin-related symptoms of plaque psoriasis.
How Does Tremfya Work?
Answer: Tremfya is a biologic medication that works by blocking a certain type of protein called interleukin (IL) 23. IL-23 is a key component in the inflammatory cascade that causes plaque psoriasis. By blocking IL-23, Tremfya reduces the inflammation and helps to improve skin-related symptoms associated with plaque psoriasis.
What are the Side Effects of Tremfya?
Answer: Common side effects of Tremfya include injection site reactions, upper respiratory infections, and headache. Serious side effects may include serious infections, allergic reactions, and changes in liver enzymes.
How is Tremfya Administered?
Answer: Tremfya is administered as an injection under the skin. It is given once every 8 weeks as a 60 mg dose. The injection site should be rotated each time it is given.
What is the Cost of Tremfya?
Answer: The cost of Tremfya varies depending on the pharmacy and insurance coverage. Without insurance, the cost of a single 60 mg dose is typically around $4,000, but may be lower with insurance coverage or if you use a coupon.
Tremfya is a revolutionary medication that has proven to be a powerful tool in treating chronic plaque psoriasis. It is produced by Janssen Biotech, Inc., a division of Johnson & Johnson. Janssen Biotech is dedicated to bringing innovative treatments to patients, and Tremfya is a testament to their commitment to providing cutting-edge medical solutions. Tremfya has been clinically proven to provide relief from psoriasis symptoms, and its continued development by Janssen Biotech is a testament to their unwavering commitment to the health of their patients.